| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 3.45e-03 | 26 | 63 | 2 | 1.25.40.90 | |
| Domain | ZnF_U1 | 4.29e-03 | 29 | 63 | 2 | SM00451 | |
| Domain | Znf_U1 | 4.29e-03 | 29 | 63 | 2 | IPR003604 | |
| Domain | ENTH_VHS | 4.29e-03 | 29 | 63 | 2 | IPR008942 | |
| Pubmed | 6.25e-07 | 263 | 65 | 7 | 34702444 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.39e-06 | 430 | 65 | 8 | 35044719 | |
| Pubmed | UBXN4 POM121 ATXN2 UNC5B SIPA1L3 NACA NUMB TMEM131 C2orf49 PPID NSDHL | 2.43e-06 | 1007 | 65 | 11 | 34597346 | |
| Pubmed | 2.65e-06 | 469 | 65 | 8 | 27634302 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 ZBTB7A PTPN4 USF3 ATXN2 SIPA1L3 NUMB ZFHX3 RPRD2 GNAS EIF4G3 DENND2B AFF4 | 3.17e-06 | 1489 | 65 | 13 | 28611215 |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 3.44e-06 | 2 | 65 | 2 | 10873665 | |
| Pubmed | The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass. | 3.44e-06 | 2 | 65 | 2 | 24550008 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.23e-06 | 351 | 65 | 7 | 38297188 | |
| Pubmed | TAF3 ATXN2 BAZ1A SIPA1L3 NACA NUMB GNAS PTBP1 C2orf49 AFF4 MGME1 NSDHL | 7.81e-06 | 1371 | 65 | 12 | 36244648 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B LIG3 TAF3 ATXN2 BAZ1A RPRD2 PTBP1 C2orf49 L3MBTL3 AFF4 | 1.05e-05 | 954 | 65 | 10 | 36373674 |
| Pubmed | ZNF462 BCL9L LIG3 ZBTB7A TAF3 ZFHX4 ATXN2 ZNF592 NACA ZFHX3 RPRD2 L3MBTL3 | 1.18e-05 | 1429 | 65 | 12 | 35140242 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.30e-05 | 583 | 65 | 8 | 29844126 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.75e-05 | 608 | 65 | 8 | 36089195 | |
| Pubmed | 1.83e-05 | 83 | 65 | 4 | 9039502 | ||
| Pubmed | BCL9L ZBTB7A UBXN4 ATXN2 ZNF592 BAZ1A SIPA1L3 NACA NUMB ZFHX3 EIF4G3 AFF4 | 1.88e-05 | 1497 | 65 | 12 | 31527615 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20032198 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 23300874 | ||
| Pubmed | 4.27e-05 | 103 | 65 | 4 | 32744500 | ||
| Pubmed | 5.88e-05 | 529 | 65 | 7 | 14621295 | ||
| Pubmed | 6.56e-05 | 733 | 65 | 8 | 34672954 | ||
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 7.18e-05 | 7 | 65 | 2 | 26816381 | |
| Pubmed | 1.01e-04 | 48 | 65 | 3 | 22242598 | ||
| Pubmed | 1.17e-04 | 591 | 65 | 7 | 15231748 | ||
| Pubmed | 1.32e-04 | 418 | 65 | 6 | 34709266 | ||
| Pubmed | 1.94e-04 | 284 | 65 | 5 | 15057824 | ||
| Pubmed | 2.18e-04 | 62 | 65 | 3 | 20403997 | ||
| Pubmed | RBM24 is a major regulator of muscle-specific alternative splicing. | 2.24e-04 | 12 | 65 | 2 | 25313962 | |
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 25916881 | ||
| Pubmed | 3.20e-04 | 493 | 65 | 6 | 15368895 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 3.41e-04 | 321 | 65 | 5 | 32098917 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.42e-04 | 934 | 65 | 8 | 33916271 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 29517884 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.67e-04 | 180 | 65 | 4 | 35198878 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.97e-04 | 332 | 65 | 5 | 30595499 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.99e-04 | 184 | 65 | 4 | 32908313 | |
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 4.06e-04 | 16 | 65 | 2 | 16096065 | |
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 21383967 | ||
| Pubmed | G-Protein α-Subunit Gsα Is Required for Craniofacial Morphogenesis. | 4.59e-04 | 17 | 65 | 2 | 26859889 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.33e-04 | 759 | 65 | 7 | 35915203 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 5.81e-04 | 361 | 65 | 5 | 26167880 | |
| Pubmed | 6.39e-04 | 20 | 65 | 2 | 35177643 | ||
| Pubmed | 7.70e-04 | 808 | 65 | 7 | 20412781 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.80e-04 | 220 | 65 | 4 | 35785414 | |
| Pubmed | 8.06e-04 | 222 | 65 | 4 | 37071664 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 8.98e-04 | 1082 | 65 | 8 | 38697112 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 9.36e-04 | 605 | 65 | 6 | 28977666 | |
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 25108383 | ||
| Pubmed | 1.02e-03 | 105 | 65 | 3 | 22505724 | ||
| Pubmed | Rex1/Zfp42 as an epigenetic regulator for genomic imprinting. | 1.17e-03 | 27 | 65 | 2 | 21233130 | |
| Pubmed | Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. | 1.45e-03 | 30 | 65 | 2 | 20080650 | |
| Pubmed | 1.46e-03 | 660 | 65 | 6 | 32780723 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 1.64e-03 | 269 | 65 | 4 | 30442662 | |
| Pubmed | 1.64e-03 | 124 | 65 | 3 | 23000965 | ||
| Pubmed | 1.72e-03 | 126 | 65 | 3 | 16284245 | ||
| Pubmed | The Trim family of genes and the retina: Expression and functional characterization. | 1.75e-03 | 33 | 65 | 2 | 30208054 | |
| Pubmed | 1.75e-03 | 33 | 65 | 2 | 27100196 | ||
| Pubmed | Vti1b promotes TRPV1 sensitization during inflammatory pain. | 1.76e-03 | 127 | 65 | 3 | 30335684 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 1.84e-03 | 468 | 65 | 5 | 31056421 | |
| Interaction | NUP43 interactions | TDRD7 ZNF462 PDS5B BCL9L LIG3 TAF3 POM121 ZNF592 BAZ1A ZFHX3 EIF4G3 MYSM1 | 5.36e-07 | 625 | 64 | 12 | int:NUP43 |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.19e-05 | 25 | 45 | 3 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.23e-04 | 15 | 45 | 2 | 529 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 6.28e-07 | 199 | 65 | 7 | M9236 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TDRD7 PDS5B PTPN4 CRIM1 ATXN2 BAZ1A SPC25 NUMB ZFHX3 TMEM131 EIF4G3 DENND2B | 1.12e-06 | 856 | 65 | 12 | M4500 |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 6.46e-06 | 184 | 65 | 6 | M6739 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN | 7.28e-06 | 50 | 65 | 4 | M5077 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 2.80e-05 | 807 | 65 | 10 | M16651 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 5.83e-05 | 166 | 65 | 5 | M6701 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 8.88e-05 | 94 | 65 | 4 | M18108 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 1.06e-04 | 303 | 65 | 6 | M39040 | |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | 1.31e-04 | 197 | 65 | 5 | M5548 | |
| Coexpression | GSE13306_TREG_VS_TCONV_UP | 1.34e-04 | 198 | 65 | 5 | M3229 | |
| Coexpression | GSE360_DC_VS_MAC_DN | 1.34e-04 | 198 | 65 | 5 | M5173 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN | 1.37e-04 | 199 | 65 | 5 | M5206 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.40e-04 | 200 | 65 | 5 | M9472 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | 1.40e-04 | 200 | 65 | 5 | M5154 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN | 1.40e-04 | 200 | 65 | 5 | M3729 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BCELL_UP | 1.40e-04 | 200 | 65 | 5 | M5515 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.54e-04 | 466 | 65 | 7 | M13522 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.56e-04 | 42 | 65 | 3 | MM3791 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-06 | 165 | 65 | 5 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.35e-06 | 189 | 65 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-06 | 192 | 65 | 5 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 9.96e-06 | 196 | 65 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 197 | 65 | 5 | 4d63a274828ebb951db78421c2823453d862cd49 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.05e-05 | 198 | 65 | 5 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.07e-05 | 199 | 65 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-05 | 200 | 65 | 5 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 65 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.39e-05 | 141 | 65 | 4 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.68e-05 | 149 | 65 | 4 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | Control-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 8.60e-05 | 159 | 65 | 4 | 6f50c381cd8a26a5a90bf0ce909713cea96910d7 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.81e-05 | 160 | 65 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 9.24e-05 | 162 | 65 | 4 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.02e-04 | 166 | 65 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 170 | 65 | 4 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 175 | 65 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 175 | 65 | 4 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.36e-04 | 179 | 65 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-04 | 180 | 65 | 4 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 180 | 65 | 4 | 4fb95ed39508bede5472dd36aeabe91b33631726 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 181 | 65 | 4 | 59527ad218e49386b04cabb97d53d2ed55a35961 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.47e-04 | 70 | 65 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 183 | 65 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 186 | 65 | 4 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 186 | 65 | 4 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 186 | 65 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 186 | 65 | 4 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 187 | 65 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.64e-04 | 188 | 65 | 4 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-04 | 189 | 65 | 4 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 189 | 65 | 4 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 189 | 65 | 4 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 190 | 65 | 4 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 190 | 65 | 4 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.71e-04 | 190 | 65 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 191 | 65 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-04 | 191 | 65 | 4 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.78e-04 | 192 | 65 | 4 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | a9349ed5f3c34dcf817b3e84737e5946922ddff3 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.81e-04 | 193 | 65 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 193 | 65 | 4 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.85e-04 | 194 | 65 | 4 | e75b0e3d2c49311b20346af67b3be936a39243b2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 194 | 65 | 4 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 195 | 65 | 4 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 195 | 65 | 4 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-04 | 195 | 65 | 4 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.88e-04 | 195 | 65 | 4 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.92e-04 | 196 | 65 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.92e-04 | 196 | 65 | 4 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-04 | 196 | 65 | 4 | ae9bf04531b9bda819608d90736c4405a6c3df41 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.92e-04 | 196 | 65 | 4 | aec2b11a6048048820271266fdc8b8d806da9993 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.92e-04 | 196 | 65 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-04 | 196 | 65 | 4 | aa0dc04f94a575cd442ee473b75a4f54268e4105 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-04 | 196 | 65 | 4 | 502834a16d5ada93af7ab9af0c3dc652086964bd | |
| ToppCell | Control-Lymphoid_T/NK-gd_T|Control / Disease group, lineage and cell class | 1.92e-04 | 196 | 65 | 4 | 98b11aada6bc5d928ef618573dc912d4d74a1092 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 88dc4e3efd7ea07617ecde142ec47cc57608f81b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 196 | 65 | 4 | 60f5deb97f3d6f8422bb5849778205a7022002ae | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.92e-04 | 196 | 65 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.96e-04 | 197 | 65 | 4 | c1c47db5e8d1b248bc192556275edd1ce168a953 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 197 | 65 | 4 | 15a08b04acb1cb7e84aeb072c650ce07374181f5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-04 | 197 | 65 | 4 | 59b1fb93a39dcf8c994d2b7dc2906dae74c57527 | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.96e-04 | 197 | 65 | 4 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 197 | 65 | 4 | e5ab45cfe4ebd02ca25029d87bece70dfbb4adc4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 198 | 65 | 4 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.00e-04 | 198 | 65 | 4 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 198 | 65 | 4 | 3222d064b6ecab0caa450a59fc1dc79e26fc6fd5 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 2.00e-04 | 198 | 65 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 198 | 65 | 4 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.00e-04 | 198 | 65 | 4 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 2.00e-04 | 198 | 65 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 2.00e-04 | 198 | 65 | 4 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.04e-04 | 199 | 65 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.04e-04 | 199 | 65 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | e751eb67510f8a5842dcfed44134160919cdb713 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-04 | 200 | 65 | 4 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-gd_T|Control / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 88e502c141bbb73e62aa5830d24bd645376e5f3a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-04 | 200 | 65 | 4 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-04 | 200 | 65 | 4 | 22892afca3666e944102c231b3f10340d8391364 | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 3451_DN | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 7310_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2005_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 6773_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 5262_DN | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 5302_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 3354_UP | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 5474_DN | |
| Disease | Albright's hereditary osteodystrophy (implicated_via_orthology) | 4.49e-06 | 2 | 63 | 2 | DOID:0080053 (implicated_via_orthology) | |
| Disease | Cis-4-decenoyl carnitine measurement | 4.47e-05 | 5 | 63 | 2 | EFO_0022091 | |
| Disease | total blood protein measurement | 4.78e-05 | 449 | 63 | 7 | EFO_0004536 | |
| Disease | birth weight, parental genotype effect measurement | 5.73e-05 | 192 | 63 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | red blood cell density measurement | ZNF462 ZBTB7A TAF3 ATXN2 BAZ1A EIF4G3 L3MBTL3 ANKRD55 DENND2B | 1.00e-04 | 880 | 63 | 9 | EFO_0007978 |
| Disease | tumor necrosis factor receptor II measurement | 1.25e-04 | 8 | 63 | 2 | EFO_0008384 | |
| Disease | octanoylcarnitine measurement | 1.60e-04 | 9 | 63 | 2 | EFO_0021042 | |
| Disease | Mitochondrial DNA Deletion Syndromes | 1.60e-04 | 9 | 63 | 2 | cv:CN043632 | |
| Disease | Cachexia | 2.92e-04 | 12 | 63 | 2 | C0006625 | |
| Disease | Alzheimer disease, cognitive decline measurement, Cognitive impairment | 3.45e-04 | 13 | 63 | 2 | EFO_0007710, HP_0100543, MONDO_0004975 | |
| Disease | reticulocyte measurement | ATXN2 BAZ1A LPIN2 TMEM131 SLCO1B1 L3MBTL3 ANKRD55 DENND2B PTHLH | 3.80e-04 | 1053 | 63 | 9 | EFO_0010700 |
| Disease | body surface area | 4.34e-04 | 643 | 63 | 7 | EFO_0022196 | |
| Disease | breast size | 4.40e-04 | 69 | 63 | 3 | EFO_0004884 | |
| Disease | blood phosphate measurement | 5.31e-04 | 174 | 63 | 4 | EFO_0010972 | |
| Disease | cortical thickness | 5.67e-04 | 1113 | 63 | 9 | EFO_0004840 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 5.98e-04 | 17 | 63 | 2 | EFO_0800030 | |
| Disease | retinal vasculature measurement | 8.20e-04 | 517 | 63 | 6 | EFO_0010554 | |
| Disease | serum non-albumin protein measurement | 1.05e-03 | 361 | 63 | 5 | EFO_0004568 | |
| Disease | free androgen index | 1.23e-03 | 374 | 63 | 5 | EFO_0007005 | |
| Disease | brain cancer (implicated_via_orthology) | 1.41e-03 | 26 | 63 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | mean platelet volume | 1.43e-03 | 1020 | 63 | 8 | EFO_0004584 | |
| Disease | mean reticulocyte volume | 1.54e-03 | 799 | 63 | 7 | EFO_0010701 | |
| Disease | cardiac arrhythmia | 1.88e-03 | 30 | 63 | 2 | EFO_0004269 | |
| Disease | serum IgA measurement | 2.00e-03 | 31 | 63 | 2 | EFO_0004912 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKPPPQASFTSNAFR | 126 | Q9BVC5 | |
| NEPNSQSKFPIFRFP | 391 | Q9H7T0 | |
| PFTRNNLAPLPDQKF | 561 | Q3KP44 | |
| VFSEPPKPSITSNNF | 141 | Q14002 | |
| SPQDRKYNSPPTQLS | 531 | P78524 | |
| PPQIQPFSQDDFLRS | 451 | Q8NEG7 | |
| RKSANNTPENSPNFP | 1361 | Q9NRL2 | |
| NTPENSPNFPNFRVI | 1366 | Q9NRL2 | |
| TVPPSADEKSNPNFF | 81 | Q9UHB7 | |
| ANKVDLSFSPAQSPP | 561 | P20742 | |
| PVLPARFFTQPDKNF | 1091 | Q9NTI5 | |
| TFFRLDRPLPPQKNF | 306 | P29074 | |
| PASPSFPRNKRTDAN | 606 | Q96JM7 | |
| FPTPEPTLNTNFVNL | 51 | A0AUZ9 | |
| FPIFNPERSDKPNAS | 101 | Q9BQP7 | |
| PNAKEFNPRSFSQPK | 916 | Q99700 | |
| QNPAKKARFSSFQTP | 296 | A6NNH2 | |
| SPSPDFYKQSSPNLQ | 736 | Q9Y5F6 | |
| SLPQTPRKDFTQLFP | 261 | O15264 | |
| PRKDFTQLFPRASPQ | 266 | O15264 | |
| LFQPLSFQSQGSPPK | 561 | Q9NZ52 | |
| TNPRKFSGFSAKPNN | 221 | P49916 | |
| PSPAPKQSFLFGTQN | 696 | Q96HA1 | |
| FSNNHPSTPKRFPRQ | 46 | Q6PB30 | |
| ANPFLERPQSFISPQ | 181 | Q9Y6W3 | |
| NFSKTSRPEFPETPN | 156 | I3L273 | |
| SLPFKRTPPNFQSQD | 111 | Q9UKA2 | |
| IISQPNAFPFTTPKA | 161 | Q6ZNA5 | |
| PQVSRSPFKPGFQEN | 761 | Q9P278 | |
| SSTLQYFPKSENQPP | 1336 | Q86UU0 | |
| DQPFRPSLSRNNSVP | 736 | Q9NZV1 | |
| FPTNENPRPLSFQSE | 81 | Q6UXQ4 | |
| PRFPQSTYQFKTPES | 266 | P55285 | |
| KPNGTNPSVFSFLNP | 546 | Q13003 | |
| RNLPSSAQPFIPKSF | 576 | Q5VT52 | |
| MNSQPQTRSPFFQRP | 1 | O43432 | |
| TNPSPTNPFSSDLQK | 631 | P49757 | |
| PNVSPEKRKNPFNSS | 151 | Q9HCH5 | |
| IPSFPVSKNNVLQFP | 96 | Q5VWG9 | |
| LEFRPPSRPQSSDNQ | 76 | O43236 | |
| PEVSRPNFQVLNPAF | 71 | Q5JWF2 | |
| PQAKPSNPSNPRVFF | 6 | Q08752 | |
| QPSPFQLSASVPKSF | 1431 | O60292 | |
| SPPPSSNNKELFYRV | 106 | Q15738 | |
| NNRFSPKASLQPPLQ | 186 | Q8NHU6 | |
| TPKPSISSSNFNPRE | 146 | Q13046 | |
| ISSIPFFFLPQTPNK | 271 | Q9Y6L6 | |
| FIFTNIDPKNPESPF | 156 | Q9HBM1 | |
| QRNKDSPYNFSNPPI | 2141 | Q86UP3 | |
| FSRDQKSLLPPPNQS | 991 | Q8IVF5 | |
| TQPSDFPQKPIQRYS | 171 | Q9HAI6 | |
| KSEPLPTFNQFSPIS | 131 | Q92610 | |
| DNRPPALAKFLPNSQ | 1531 | Q92545 | |
| SSNLTLPPKYNQPFF | 936 | P29144 | |
| LFPPSNNFVTPALRQ | 1401 | Q68DE3 | |
| SPPSFLPLANQQLFR | 421 | Q5SNT2 | |
| FHPVNFKTARPSNPQ | 421 | Q8IZJ1 | |
| NSKPSPNTKNHPVRF | 81 | P12272 | |
| VPPQVRNFNFPKDNT | 541 | Q9UJ78 | |
| NQPEFDVFSQSPPKL | 1601 | Q96JM2 | |
| NFLFSNPPPTQTSVR | 431 | Q92575 | |
| PGSKNFQNIFPPSAT | 441 | P26599 | |
| LEFFQSNPMNSLPPA | 161 | O95365 | |
| RQRNKDSPYNFSNPP | 2201 | Q15911 | |
| FPLLSKEQNSAFPCP | 861 | Q92539 | |
| PLVQAAPKNSPSFQS | 561 | E9PAV3 | |
| PTKSSFDPFQLIPCN | 551 | Q5VVJ2 |